Delivery Order HT940622D0001-HT940622F0003
Award Date
1/20/22
Potential Completion Date
2/18/22
Potential Value
$321K
Federal Agency
Defense Health Agency
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>
The Defense Health Agency (DOD) awarded a $357,330 firm fixed price purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide 95 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 28 Aptima SARS-CoV-2 control boxes containing 5 positive and 5 negative controls per box, and 20 Fusion specimen lysis tubes containing 100 bags per box. The place of performance is Marlborough, Massachusetts and the period of performance is from January 24, 2022...
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
The Defense Health Agency (DOD) awarded a $339,005 purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide COVID-19 test kits and supplies. The place of performance is Bethesda, Maryland and the contract period is from January 28, 2022 to February 10, 2022. The pricing structure is firm fixed price. Gen-Probe Incorporated will supply coronavirus disease 2019 test kits and related materials to the Defense Health Agency to support continued testing...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
The Defense Health Agency awarded a $745,185 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for 94 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 47 Aptima SARS-CoV-2 control boxes with five positive and five negative controls per box, and 235 Fusion specimen lysis tubes in 100 bags per box. The place of performance is in Marlborough, Massachusetts and the period of performance runs from February 17, 2022 through September 30, 2023....
<p>The Defense Health Agency awarded a $402,125 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide APTIMA SARS-COV-2 ASSAY, EUA APTIMA CONTROLS, FUSION SPECIMEN LYSIS, AND PANTHER RUN KIT products and services. The place of performance will be in Marlborough, Massachusetts over a period starting July 20, 2022 and ending September 29, 2022 to support the agency's Coronavirus COVID-19 National Interest Action.</p>
This is a $158,550.00 Firm Fixed Price Delivery Order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The contract is for the provision of COVID-19 assays, with an ultimate completion date of January 15, 2021. Gen-Probe is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases. This award is not associated...
The Defense Health Agency awarded a $2,300 firm fixed price delivery order contract to Gen-Probe Incorporated for COVID19 reagents. The contract has no set aside designation and requires performance in Marlborough, Massachusetts by March 23, 2021. Gen-Probe Sales & Service, Inc. will perform as a division of Gen-Probe Incorporated. The contract was awarded on March 16, 2021 under the National Interest Action Code for Coronavirus COVID-19 in support of the Defense Health Agency's response...
The Defense Health Agency awarded a $127,590 firm fixed price delivery order contract to Gen-Probe Incorporated for COVID19 reagents. The contract has a period of performance through September 30, 2020 to support the agency's response to the Coronavirus pandemic. Gen-Probe Sales & Service, Inc. will perform the work at their Marlborough, Massachusetts location. No set-aside provisions were applied to this award to procure reagents needed for COVID19 testing. The contract was issued under the...